NCT02724202 2026-02-06
Curcumin in Combination With 5FU for Colon Cancer
Baylor Research Institute
Phase EARLY_PHASE1 Terminated
Clinical Trials
157 trialsNCT05316116 2026-02-05
Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Terminated
NCT04044872 2026-02-02
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT04825275 2026-01-23
Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial
Milton S. Hershey Medical Center
Phase EARLY_PHASE1 Terminated
NCT04869449 2026-01-07
Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas
Milton S. Hershey Medical Center
Phase EARLY_PHASE1 Terminated
NCT04424966 2025-10-24
Infigratinib in Recurrent High-Grade Glioma Patients
St. Joseph's Hospital and Medical Center, Phoenix
Phase EARLY_PHASE1 Terminated
NCT04712721 2025-10-10
Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
Novartis
Phase EARLY_PHASE1 Terminated
NCT06516510 2025-09-25
A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer
Blue Earth Therapeutics Ltd
Phase EARLY_PHASE1 Terminated
NCT04074785 2025-08-17
SCCC-06319
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT03579446 2025-08-03
Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Terminated
NCT05841706 2025-06-10
Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT04034446 2025-06-03
CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)
Institute of Hematology & Blood Diseases Hospital, China
Phase EARLY_PHASE1 Terminated
NCT04237649 2025-05-18
KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors
Novartis
Phase EARLY_PHASE1 Terminated
NCT06001372 2025-04-16
TREK
University of Utah
Phase EARLY_PHASE1 Terminated
NCT05322135 2025-04-09
A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Terminated
NCT02827838 2025-03-17
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Terminated
NCT06110208 2025-02-26
Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Phase EARLY_PHASE1 Terminated
NCT04213794 2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1 Terminated
NCT04906382 2025-02-13
Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT02714439 2025-01-15
Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley
The University of Texas Medical Branch, Galveston
Phase EARLY_PHASE1 Terminated
NCT03514121 2024-11-22
FPA150-001
Five Prime Therapeutics, Inc.
Phase EARLY_PHASE1 Terminated
NCT04630886 2024-11-19
Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery
University of Massachusetts, Worcester
Phase EARLY_PHASE1 Terminated
NCT02748798 2024-10-15
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
Thunder Bay Regional Health Research Institute
Phase EARLY_PHASE1 Terminated
NCT03796273 2024-09-19
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Terminated
NCT05284032 2024-07-31
A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001)
University of Virginia
Phase EARLY_PHASE1 Terminated
NCT04221061 2024-06-17
18F-FluorThanatrace (PET/CT) in Glioblastoma
University of Pennsylvania
Phase EARLY_PHASE1 Terminated
NCT03492164 2024-06-12
In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Terminated
NCT04199754 2024-05-31
IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy
Columbia University
Phase EARLY_PHASE1 Terminated
NCT03893019 2024-05-16
MB-CART20.1 Melanoma
Miltenyi Biomedicine GmbH
Phase EARLY_PHASE1 Terminated
NCT03519308 2024-03-15
A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Terminated
NCT01764451 2024-03-12
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
University of New Mexico
Phase EARLY_PHASE1 Terminated
NCT03812562 2024-02-21
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
Northwestern University
Phase EARLY_PHASE1 Terminated
NCT03818776 2024-02-15
Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable NSCLC
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT03870529 2024-01-09
High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Terminated
NCT03972943 2024-01-08
CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia
University of Utah
Phase EARLY_PHASE1 Terminated
NCT04803123 2023-12-21
Window Trial to Evaluate Molecular Response to PI3K Inhibition With Copanlisib in r/r Adult B-cell ALL
Duke University
Phase EARLY_PHASE1 Terminated
NCT03451123 2023-12-19
FET-PET/MRI for Surgical Assessment of Pediatric Brain Tumors
University of Alabama at Birmingham
Phase EARLY_PHASE1 Terminated
NCT04663126 2023-12-13
Tilmanocept
University of Lausanne Hospitals
Phase EARLY_PHASE1 Terminated
NCT02382549 2023-12-12
Mel61
University of Virginia
Phase EARLY_PHASE1 Terminated
NCT02676050 2023-12-04
DUAL
University of Edinburgh
Phase EARLY_PHASE1 Terminated
NCT03694834 2023-11-28
Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT03724409 2023-11-28
Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases
University of Iowa
Phase EARLY_PHASE1 Terminated
NCT00736450 2023-10-24
Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
University of Nebraska
Phase EARLY_PHASE1 Terminated
NCT04020419 2023-10-23
Pediaberry
Indiana University
Phase EARLY_PHASE1 Terminated
NCT04116164 2023-09-25
Safety and Targeting of Anti-hk2 Antibody in mCRPC
SpectronRX
Phase EARLY_PHASE1 Terminated
NCT01755650 2023-09-13
Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies
Peter MacCallum Cancer Centre, Australia
Phase EARLY_PHASE1 Terminated
NCT03224819 2023-09-01
Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)
Amgen
Phase EARLY_PHASE1 Terminated
NCT02774291 2023-08-04
Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes
Albert Einstein College of Medicine
Phase EARLY_PHASE1 Terminated
NCT03272633 2023-06-26
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
Rutgers, The State University of New Jersey
Phase EARLY_PHASE1 Terminated
NCT02640209 2023-06-22
Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 Chimeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Small Lymphocytic Lymphoma (SLL)
University of Pennsylvania
Phase EARLY_PHASE1 Terminated